Edition:
United States

USANA Health Sciences Inc (USNA.N)

USNA.N on New York Stock Exchange

64.35USD
26 May 2017
Change (% chg)

$0.10 (+0.16%)
Prev Close
$64.25
Open
$64.10
Day's High
$64.60
Day's Low
$63.75
Volume
26,345
Avg. Vol
40,608
52-wk High
$74.97
52-wk Low
$52.55

Latest Key Developments (Source: Significant Developments)

USANA Health Sciences promotes Doug Hekking to CFO
Friday, 5 May 2017 03:29pm EDT 

May 5 (Reuters) - USANA Health Sciences Inc ::Appointment of chief executive officer Kevin Guest to company's board of directors.Says promoting Doug Hekking to chief financial officer.  Full Article

USANA Health Sciences Q1 earnings per share $0.91 excluding items
Tuesday, 2 May 2017 04:17pm EDT 

May 2 (Reuters) - USANA Health Sciences Inc ::USANA Health Sciences reports first quarter financial results.Q1 earnings per share $0.91, excluding items.Q1 sales rose 6.2 percent to $255.3 million.Sees FY 2017 earnings per share $3.80 to $4.10.Sees FY 2017 sales $1.04 billion to $1.07 billion.Q1 earnings per share $0.86.Company reiterates 2017 outlook.G. Douglas Hekking named as new Chief Financial Officer.Qtrly earnings were impacted by additional expense related to previously disclosed internal investigation during quarter.  Full Article

USANA names new chief field development officer, two executive vice presidents
Wednesday, 8 Feb 2017 02:00pm EST 

USANA Health Sciences Inc : Usana names new chief field development officer, two executive vice presidents . Usana health -david mulham, former executive vice president of americas, pacific and europe, has been named chief field development officer . Usana health -brent neidig, former vice president of china strategic development, has been named executive vice president of china .Usana health sciences inc says josh foukas, former vice president of legal, has been named executive vice president of legal.  Full Article

Usana Health Sciences reports Q4 earnings per share $0.87
Tuesday, 7 Feb 2017 04:15pm EST 

Usana Health Sciences Inc : Usana Health Sciences reports fourth quarter and full-year financial results . Q4 earnings per share $0.87 . Q4 sales $252.9 million versus i/b/e/s view $253.5 million . Sees FY 2017 earnings per share $3.80 to $4.10 . Sees FY 2017 sales $1.04 billion to $1.07 billion . Q4 earnings per share view $0.94 -- Thomson Reuters I/B/E/S .FY 2017 earnings per share view $4.47, revenue view $1.11 billion -- Thomson Reuters I/B/E/S.  Full Article

Usana Health Sciences names Jim Brown as COO
Wednesday, 7 Dec 2016 04:15pm EST 

Usana Health Sciences Inc : Says Jim Brown has been appointed president and chief operations officer of company .Usana appoints new president and CIO.  Full Article

Usana Health Sciences says Q2 earnings per share $2.07
Tuesday, 26 Jul 2016 04:20pm EDT 

Usana Health Sciences Inc : Company reiterated its consolidated net sales outlook for 2016 . Sees 2016 earnings per share between $7.90 and $8.20 . Usana health sciences reports record second quarter financial results . Q2 earnings per share $2.07 . Q2 sales $258.5 million versus i/b/e/s view $256.7 million . Q2 earnings per share view $2.05 -- Thomson Reuters I/B/E/S .Fy2016 earnings per share view $8.01, revenue view $1.02 billion -- Thomson Reuters I/B/E/S.  Full Article

USANA Health Sciences Increases Share Repurchase Authorization by $100 Million
Tuesday, 8 Dec 2015 07:00pm EST 

USANA Health Sciences:Says Board of Directors has authorized an additional $100 million in funding for share repurchases by the Company of its outstanding common stock.  Full Article

USANA Health Sciences Inc raises FY 2015 EPS guidance; raises low end of prior FY 2015 revenue guidance
Tuesday, 3 Nov 2015 04:17pm EST 

USANA Health Sciences Inc:Updated consolidated net sales and earnings per share outlook for FY 2015.Sees FY 2015 Consolidated net sales between $915 million and $920 million, versus the previous outlook of between $900 million and $920 million.Sees FY 2015 Earnings per share between $7.25 and $7.35, versus the previous outlook of between $6.90 and $7.20.FY 2015 revenue of $917 million and EPS of $7.16 - Thomson Reuters I/B/E/S.  Full Article

USANA board appoints Dave Wentz, Kevin Guest as co-CEO's
Tuesday, 4 Aug 2015 04:17pm EDT 

USANA Health Sciences Inc:Board of directors appoints dave wentz and kevin guest as co-chief executive officers.Says wentz will oversee usana's global operations.Says guest will lead usana's worldwide field development and sales efforts.Says paul jones, chief financial officer, has been appointed chief leadership development officer.Says jones will continue his CFO responsibilities while the company initiates a search for a new chief financial officer.  Full Article

USANA Health Sciences Inc raises FY 2015 guidance
Tuesday, 4 Aug 2015 04:07pm EDT 

USANA Health Sciences Inc:Expects FY 2015 consolidated net sales between $900 million and $920 million, versus the previous outlook of between $870 million and $890 million.Expects FY 2015 Earnings per share between $6.90 and $7.20, versus the previous outlook of between $6.45 and $6.75.FY 2015 revenue of $885 million and EPS of $6.70 - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Pollard banknote responds to filing of Innova Gaming Circular

* Pollard Banknote- responded to filing of Innova Gaming Circular in connection with offer of co to buy all common shares of Innova for $2.10 per share